127 related articles for article (PubMed ID: 28868371)
1. Inactive Carriers of Hepatitis B Virus: A Never Ending Story.
Macedo G
GE Port J Gastroenterol; 2015; 22(2):43-44. PubMed ID: 28868371
[No Abstract] [Full Text] [Related]
2. Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.
Riveiro-Barciela M; Bes M; Rodríguez-Frías F; Tabernero D; Ruiz A; Casillas R; Vidal-González J; Homs M; Nieto L; Sauleda S; Esteban R; Buti M
Clin Microbiol Infect; 2017 Nov; 23(11):860-867. PubMed ID: 28288829
[TBL] [Abstract][Full Text] [Related]
3. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
[TBL] [Abstract][Full Text] [Related]
4. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
Chu CM; Chen YC; Tai DI; Liaw YF
Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
[TBL] [Abstract][Full Text] [Related]
5. The evolving scenario of HBV infection and disease: A never-ending story.
Milana M; Angelico M
Dig Liver Dis; 2019 Mar; 51(3):443-444. PubMed ID: 30470554
[No Abstract] [Full Text] [Related]
6. Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.
Yim SY; Um SH; Jung JY; Seo YS; Yim HJ; Ryu HS; Chun HJ; Jeen YT; Kim CD; Keum B; Lee HS
J Clin Gastroenterol; 2014 Feb; 48(2):166-71. PubMed ID: 24045280
[TBL] [Abstract][Full Text] [Related]
7. The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study.
Taida T; Arai M; Kanda T; Hige S; Ueno Y; Imazeki F; Izumi N; Tanaka E; Shinkai N; Yoshioka K; Nakamoto Y; Nishiguchi S; Tsuge M; Abe M; Sata M; Yatsuhashi H; Ido A; Kita K; Azemoto R; Kitsukawa Y; Goto N; Yokosuka O
J Gastroenterol; 2017 Jan; 52(1):113-122. PubMed ID: 27306374
[TBL] [Abstract][Full Text] [Related]
8. Hepatogastroenterologists' knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey.
Causse X; Cadranel JF; Potier P; Hanslik B; Denis J; Renou C; Delasalle P; ;
Eur J Gastroenterol Hepatol; 2015 May; 27(5):544-9. PubMed ID: 25822863
[TBL] [Abstract][Full Text] [Related]
9. Serum hepatitis B virus DNA levels differentiating inactive carriers from patients with chronic hepatitis B.
Seo Y; Yoon S; Truong BX; Kato H; Hamano K; Kato M; Yano Y; Katayama M; Ninomiya T; Hayashi Y; Kasuga M
Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):753-7. PubMed ID: 15947553
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the histological and serological parameters of patients with hepatitis delta virus in active and inactive hepatitis B virus carriers.
Shaikh S; Ram DB; Tanveer S; Talpur A
J Coll Physicians Surg Pak; 2014 Feb; 24(2):97-100. PubMed ID: 24491002
[TBL] [Abstract][Full Text] [Related]
11. Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression.
Liu J; Yang HI; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Chen CJ
Hepatology; 2016 Aug; 64(2):381-9. PubMed ID: 27079545
[TBL] [Abstract][Full Text] [Related]
12. Anti-viral prophylaxis in inactive hepatitis B virus carriers with hemato-oncological malignancies who receive chemotherapy.
Idilman R
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):39-45. PubMed ID: 16554705
[TBL] [Abstract][Full Text] [Related]
13. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.
Castéra L; Bernard PH; Le Bail B; Foucher J; Trimoulet P; Merrouche W; Couzigou P; de Lédinghen V
Aliment Pharmacol Ther; 2011 Feb; 33(4):455-65. PubMed ID: 21235598
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
Chu CM; Liaw YF
Am J Gastroenterol; 2009 Jul; 104(7):1693-9. PubMed ID: 19455130
[TBL] [Abstract][Full Text] [Related]
15. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
Lee BH; Koh WJ; Choi MS; Suh GY; Chung MP; Kim H; Kwon OJ
Chest; 2005 Apr; 127(4):1304-11. PubMed ID: 15821209
[TBL] [Abstract][Full Text] [Related]
16. Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.
Zingarelli S; Frassi M; Bazzani C; Scarsi M; Puoti M; Airò P
J Rheumatol; 2009 Jun; 36(6):1188-94. PubMed ID: 19447932
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a.
Li MH; Xie Y; Zhang L; Lu Y; Shen G; Wu SL; Chang M; Mu CQ; Hu LP; Hua WH; Song SJ; Zhang SF; Cheng J; Xu DZ
World J Hepatol; 2016 May; 8(15):637-43. PubMed ID: 27239256
[TBL] [Abstract][Full Text] [Related]
18. Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up.
Brouwer WP; Chan HL; Brunetto MR; Martinot-Peignoux M; Arends P; Cornberg M; Cherubini B; Thompson AJ; Liaw YF; Marcellin P; Janssen HL; Hansen BE;
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1481-1489.e5. PubMed ID: 26872398
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers.
Mena Á; Pedreira JD; Castro Á; López S; Vázquez P; Poveda E
J Gastroenterol Hepatol; 2014 Jan; 29(1):173-8. PubMed ID: 24219115
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.
Brunetto MR; Oliveri F; Colombatto P; Moriconi F; Ciccorossi P; Coco B; Romagnoli V; Cherubini B; Moscato G; Maina AM; Cavallone D; Bonino F
Gastroenterology; 2010 Aug; 139(2):483-90. PubMed ID: 20451520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
